Patient | Gender | Age | Tumor site | T-stage, clinical | N-stage, clinical | M-stage, clinical | T-stage, path | N-stage, path | M-stage, path | HPV status |
---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 31 | OC | T3 | N0 | M0 | T2 | N1 | M0 | - |
2 | Male | 51 | OC | T4 | N1 | M0 | T4A | N0 | M0 | - |
3 | Male | 48 | OP | T2 | N2 | M0 | T3 | N2B | MX | + |
4 | Female | 68 | OC | T4A | N1 | M0 | T4A | N0 | MX | + |
5 | Male | 62 | OP | T1 | N1 | M0 | T1 | N2A | MX | + |
6 | Male | 69 | OP | T2 | N2 | M0 | T3 | N2B | MX | + |
7 | Female | 75 | OC | T4 | N0 | M0 | T4A | N0 | MX | - |
8 | Male | 65 | OC | T2 | N2 | M0 | T1 | N2A | MX | - |
9 | Male | 49 | OP | T1 | N2B | M0 | T2 | N1 | MX | + |
10 | Female | 40 | OC | T2 | N2B | M0 | T2 | N2B | MX | - |
11 | Female | 58 | OC | T3 | N2B | M0 | T2 | N2B | MX | - |
12 | Female | 83 | OC | T4A | N0 | M0 | T4A | N0 | MX | - |
13 | Male | 55 | L | T3 | N1 | M0 | T3 | N1 | MX | - |
14 | Male | 64 | OC | T1 | N1 | M0 | T1 | N1 | MX | - |
15 | Female | 51 | OP | T4 | N0 | M0 | T2 | N0 | MX | - |
16 | Male | 59 | OP | T2 | N2B | M0 | T2 | N2A | MX | + |
17 | Male | 64 | OP | T2 | N1 | M0 | T2 | N2B | MX | + |
18 | Male | 62 | OC | T2 | N0 | M0 | TX | N0 | MX | - |
19 | Male | 54 | OC | T2 | N2C | M0 | T2 | N2C | MX | - |
20 | Male | 62 | OC | T4 | N1 | M0 | T2 | N1 | MX | - |
21 | Male | 93 | OC | T4A | N0 | M0 | TX | NX | MX | - |
22 | Male | 58 | OP | T2 | N1 | M0 | T3 | N1 | MX | - |
23 | Female | 47 | OC | T4A | N1 | M0 | T4A | N1 | MX | - |
24 | Male | 59 | OC | T4A | N0 | M0 | T4A | N0 | MX | - |
25 | Male | 64 | OP | T2 | N1 | M0 | T1 | N1 | MX | + |
26 | Male | 43 | OP | T2 | N2B | M0 | T2 | N2B | MX | + |
27 | Female | 74 | L | T4 | N1 | M0 | T3 | N2C | MX | - |
28 | Female | 57 | OC | T4A | N1 | M0 | T2 | N1 | MX | - |
29 | Male | 57 | OP | T3 | N2B | M0 | T1 | N0 | MX | + |
Abbreviations: OC oral cavity, OP oropharynx, L larynx